Brief: MYOS RENS Technology Enters Into Research Agreement With Mcmaster University To Study Impact Of Fortetropin On Muscle Disuse Atrophy In Young Men
10/09/2019 13:46
Sept 10 (Reuters) - MYOS RENS Technology Inc MYOS.O :
* MYOS RENS TECHNOLOGY ENTERS INTO RESEARCH AGREEMENT WITH
MCMASTER UNIVERSITY TO STUDY IMPACT OF FORTETROPIN® ON MUSCLE
DISUSE ATROPHY IN YOUNG MEN
Source text for Eikon: ID:nPn6qWG1na
Further company coverage: MYOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medavail Holdings
See all newsBrief: Medavail Holdings Approved Reduction In Force Of About 40% Of Current Full-Time Employees
Brief: MedAvail Announces Agreement With New Orleans-Based St. Thomas Community Health Centers For Deployment Of Two M4 Medcenters
Brief: Medavail Announces Agreement With ASP Cares For Deployment Of Ten M4 Medcenters
Brief: MedAvail Announces Agreement With Oak Lawn Pharmacy For Deployment M4 Medcenters
Brief: Medavail Announces 1-For-50 Reverse Stock Split